NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.41
-2.42 (-7.39%)
Mar 3, 2026, 4:00 PM EST - Market closed
NAMS Market Cap
NAMS has a market cap or net worth of $3.5 billion as of March 3, 2026. Its market cap has increased by 68.32% in one year.
Market Cap
3.50B
Enterprise Value
2.77B
1-Year Change
68.32%
Ranking
Category
Stock Price
$30.41
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.50B, an increase of 2,163.41%. That is a compound annual growth rate of 85.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 3.77B | -5.11% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 4.26B |
| Ligand Pharmaceuticals | 4.04B |
| ADMA Biologics | 3.95B |
| ACADIA Pharmaceuticals | 3.89B |
| Centessa Pharmaceuticals | 3.87B |
| Viking Therapeutics | 3.85B |
| Corcept Therapeutics | 3.83B |
| Alumis | 3.70B |